Cargando…

L-EGCG-Mn nanoparticles as a pH-sensitive MRI contrast agent

This study aimed to synthesize and characterize L-epigallocatechin gallate (EGCG) complexed Mn(2+) nanoparticle (L-EGCG-Mn), a proof-of-concept pH-sensitive manganese core nanoparticle (NP), and compare its magnetic resonance (MR) properties with those of Gd-DTPA, both in vitro and in vivo. Reverse...

Descripción completa

Detalles Bibliográficos
Autores principales:	Li, Jiali, Jiang, Xue, Shang, Lihuan, Li, Zhen, Yang, Conglian, Luo, Yan, Hu, Daoyu, Shen, Yaqi, Zhang, Zhiping
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Taylor & Francis 2020
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7782420/ https://www.ncbi.nlm.nih.gov/pubmed/33356629 http://dx.doi.org/10.1080/10717544.2020.1862363

Ejemplares similares

Mn-Based MRI Contrast Agents: An Overview
por: Henoumont, Céline, et al.
Publicado: (2023)

PEG-Coated MnZn Ferrite Nanoparticles with Hierarchical Structure as MRI Contrast Agent
por: Cheraghali, Sedigheh, et al.
Publicado: (2023)

Use of pulmonary CT angiography with low tube voltage and low-iodine-concentration contrast agent to diagnose pulmonary embolism
por: Hu, Xuemei, et al.
Publicado: (2017)

Author Correction: Use of pulmonary CT angiography with low tube voltage and low-iodine-concentration contrast agent to diagnose pulmonary embolism
por: Hu, Xuemei, et al.
Publicado: (2018)

ATP-responsive Mn(ii)-based T(1) contrast agent for MRI
por: Anbu, Sellamuthu, et al.
Publicado: (2023)

Magnetic Nanoparticles as MRI Contrast Agents
por: Avasthi, Ashish, et al.
Publicado: (2020)

Assessing the histopathological features of rectal adenocarcinoma with chemical shift–encoded sequence (CSE)-MRI and diffusion-weighted imaging (DWI)
por: Peng, Yang, et al.
Publicado: (2023)

Correction to: Magnetic Nanoparticles as MRI Contrast Agents
por: Avasthi, Ashish, et al.
Publicado: (2021)

Enhanced oral bioavailability of EGCG using pH-sensitive polymeric nanoparticles: characterization and in vivo investigation on nephrotic syndrome rats
por: Zhang, Guojuan, et al.
Publicado: (2018)

A magnetic resonance nanoprobe with STING activation character collaborates with platinum-based drug for enhanced tumor immunochemotherapy
por: Li, Jiali, et al.
Publicado: (2021)

Enhancing cancer chemo-immunotherapy by biomimetic nanogel with tumor targeting capacity and rapid drug-releasing in tumor microenvironment
por: Shang, Lihuan, et al.
Publicado: (2022)

A scale to measure MRI contrast agent sensitivity
por: Alvares, Rohan D. A., et al.
Publicado: (2017)

Improving the sensitivity of T(1) contrast-enhanced MRI and sensitive diagnosing tumors with ultralow doses of MnO octahedrons
por: Yang, Lijiao, et al.
Publicado: (2021)

Anti-bacterial Activities of EGCG Nanoparticles
por: Fan, Baochan, et al.
Publicado: (2022)

Radiometal-Based PET/MRI Contrast Agents for Sensing Tumor Extracellular pH
por: Pollard, Alyssa C., et al.
Publicado: (2022)

Effect of Europium Substitution on the Structural, Magnetic and Relaxivity Properties of Mn-Zn Ferrite Nanoparticles: A Dual-Mode MRI Contrast-Agent Candidate
por: Saeidi, Hamidreza, et al.
Publicado: (2023)

Fe/Mn Multilayer Nanowires as High-Performance T(1)-T(2) Dual Modal MRI Contrast Agents
por: Cao, Xiaoming, et al.
Publicado: (2021)

Morphometric assessment of the mesorectal fat in Chinese Han population: A clinical MRI study
por: Tripathi, Pratik, et al.
Publicado: (2021)

Mn-Doped Nano-Hydroxyapatites as Theranostic Agents with Tumor pH-Amplified MRI-Signal Capabilities for Guiding Photothermal Therapy
por: Li, Chengyu, et al.
Publicado: (2023)

Multimodal Contrast Agent Enabling pH Sensing Based on Organically Functionalized Gold Nanoshells with Mn-Zn Ferrite Cores
por: Bui, Duong Thuy, et al.
Publicado: (2022)

Hyperpolarized (15)N-pyridine Derivatives as pH-Sensitive MRI Agents
por: Jiang, Weina, et al.
Publicado: (2015)

Contrast agents for hepatic MRI
por: Morana, Giovanni, et al.
Publicado: (2007)

MRI Contrast Agents in Glycobiology
por: Geraldes, Carlos F. G. C., et al.
Publicado: (2022)

MnDPDP: Contrast Agent for Imaging and Protection of Viable Tissue
por: Jynge, Per, et al.
Publicado: (2020)

Radiolabeled Iron Oxide Nanoparticles as Dual Modality Contrast Agents in SPECT/MRI and PET/MRI
por: Karageorgou, Maria-Argyro, et al.
Publicado: (2023)

Aluminium hydroxide stabilised MnFe(2)O(4) and Fe(3)O(4) nanoparticles as dual-modality contrasts agent for MRI and PET imaging
por: Cui, Xianjin, et al.
Publicado: (2014)

An enzyme-activatable and cell-permeable Mn(III)-porphyrin as a highly efficient T(1) MRI contrast agent for cell labeling
por: Haedicke, Inga E., et al.
Publicado: (2016)

A pH-responsive T(1)-T(2) dual-modal MRI contrast agent for cancer imaging
por: Lu, Hongwei, et al.
Publicado: (2022)

Predicting Therapeutic Efficacy of Vascular Disrupting Agent CA4P in Rats with Liver Tumors by Hepatobiliary Contrast Agent Mn-DPDP-Enhanced MRI
por: Liu, Yewei, et al.
Publicado: (2019)

Key Parameters on the Microwave Assisted Synthesis of Magnetic Nanoparticles for MRI Contrast Agents
por: Brollo, Maria Eugênia Fortes, et al.
Publicado: (2017)

Application of spin-crossover water soluble nanoparticles for use as MRI contrast agents
por: Tsukiashi, Asami, et al.
Publicado: (2018)

Functionalized Gold Nanoparticles as Contrast Agents for Proton and Dual Proton/Fluorine MRI
por: Şologan, Maria, et al.
Publicado: (2019)

Manganese Oxide Nanoparticles As MRI Contrast Agents In Tumor Multimodal Imaging And Therapy
por: Cai, Xiaoxia, et al.
Publicado: (2019)

Highly Potent MRI Contrast Agent Displaying Outstanding Sensitivity to Zinc Ions
por: Wang, Gaoji, et al.
Publicado: (2021)

Chemical Shift-Encoded Sequence (IDEAL-IQ) and Amide Proton Transfer (APT) MRI for Prediction of Histopathological Factors of Rectal Cancer
por: Peng, Yang, et al.
Publicado: (2023)

Highly water-dispersible calcium lignosulfonate-capped MnO nanoparticles as a T(1) MRI contrast agent with exceptional colloidal stability, low toxicity and remarkable relaxivity
por: Arian, Mahdi, et al.
Publicado: (2019)

MRI Contrast Agents for Pharmacological Research
por: Terreno, Enzo, et al.
Publicado: (2015)

Magnetic Nanomaterials as Contrast Agents for MRI
por: Caspani, Sofia, et al.
Publicado: (2020)

Mn(3)[Co(CN)(6)](2)@SiO(2) Core-shell Nanocubes: Novel bimodal contrast agents for MRI and optical imaging
por: Huang, Yimin, et al.
Publicado: (2013)

Effects of iron oxide nanoparticles as T(2)-MRI contrast agents on reproductive system in male mice
por: Yang, Heyu, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_upa9nlanh97sjghdkbm1e61673